质量即生命 — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

成为合作伙伴
ALIPEMETINIB
Rx
肿瘤学 & 血液学

ALIPEMETINIB

佩米替尼 (Pemigatinib)
Generic (INN)
佩米替尼 (Pemigatinib)
Strength
4.5 mg
Packaging
7 片/板，2 板/盒。
Indication
用于治疗既往接受过治疗、经检测存在成纤维细胞生长因子受体 2（FGFR2）融合或其他重排的不可切除的局部晚期或转移性胆管癌成年患者。
Registration No.
To be added
Package Insert
English & Lao (PDF)
Documents
Registration certificateTo be added
Medicine safety & reporting

More in 肿瘤学 & 血液学

View all →
ALIAVATINI
ALIAVATINI
阿伐替尼 (Avapritinib)
ALIERDATINI 3mg
ALIERDATINI 3mg
厄达替尼 (Erdafitinib)
ALIPONATIB 45mg
ALIPONATIB 45mg
普纳替尼 (Ponatinib)
ALIAXITINIB
ALIAXITINIB
阿昔替尼 (Axitinib)
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Regenerative CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Regenerative Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文